Stay updated with breaking news from Given Marimed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare MariMed to related companies based on the strength of its institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Analyst Recommendations This is a breakdown of […]
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to related companies based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation. Institutional and Insider Ownership 0.3% of MariMed […]
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare MariMed to related companies based on the strength of its institutional ownership, earnings, valuation, analyst recommendations, profitability, dividends and risk. Profitability This table compares MariMed and its […]
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its competitors? We will compare MariMed to similar companies based on the strength of its earnings, analyst recommendations, profitability, dividends, valuation, institutional ownership and risk. Risk and Volatility MariMed has a beta […]
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to related businesses based on the strength of its valuation, dividends, profitability, analyst recommendations, earnings, institutional ownership and risk. Risk and Volatility MariMed has a beta […]